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Abstract 
Background: Severe acute malnutrition (SAM) is a major global public health problem.: Mmid-
upper arm circumference (MUAC) is widely used to admit children to treatment programmes. 
However, insufficient data supporting MUAC discharge criterion scant MUAC data at programme 
discharge limits its use as a stand-alone assessment tool. Our aim was to evaluate MUAC for 
monitoring nutritional recovery and discharge.  
Methods: Secondary analysis of clinical data from children 6-59 months-old treated for SAM from, 
January 2003 to December 2013 Nutritional Rehabilitation Unit in rural Gambia. Weight, weight-for-
height z-score (WHZ) and MUAC response to treatment were assessed. Treatment indicators and 
regression models controlled for admission measurement and age were compared by discharge 
MUAC and WHZ.  
Results: 463 children with marasmus were analysedincluded. MUAC, WHZ and weight showed 
parallel responses to treatment. MUAC≥125mm as a discharge criterion performed well, showing 
even when controlling for age, sex and stunting. MUAC<125mm at discharge was as good a 
predictionor of default and referral to hospital, acceptable duration of stay, and as WHZ<-2.0 a 
higher absolute MUAC measure compared to WHZ≥-2.00, closely related to lower risk of mortality. 
Those discharged with MUAC≥125mm only, showed no difference in readmissions to those 
meeting both criteria.  
Conclusions: MUAC can be used as a standalone tool for monitoring nutritional recovery. 
MUAC≥125mm performs well as a discharge criterion, however follow-up data of children is 
needed to assess its safety. Future Further research is needed on children meeting MUAC 
discharge criterion but with WHZ<-2.0. 
Keywords: Discharge, Mid-upper arm circumference, MUAC, Severe acute malnutrition, SAM, 
Wasting 
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Introduction 
Undernutrition accounts for just under half of all deaths in children aged under 5-years worldwide. 
Severe acute malnutrition (SAM) is a particularly important type of undernutrition responsible for 
over 500,000 deaths per year.1, 2 Prevalence estimates suggest around 17 million children globally 
are currently suffering from SAM.3  
What is today called SAM comprises two forms of malnutrition: wasting and/or kwashiorkor 
(oedematous malnutrition). Wasting was initially defined by a low weight-for-height z-score (WHZ),4 
more recently an unadjusted mid-upper arm circumference (MUAC) has also been used as an 
independent criterion.5 Studies comparing the two measures found MUAC to be better than WHZ 
at predicting mortality, with deaths highest in those with a MUAC <115mm.6-9 Also stimulating the 
rise of MUAC in nutrition programming was the shift, in the 2000's, from an inpatient-focused 
model of care to the ‘Community Management of Acute Malnutrition’ (CMAM). CMAM emphasised 
high programme coverage with outpatient treatment for clinically stable (uncomplicated) SAM 
cases. Early identification of affected children and active community case finding are key to 
CMAM’s success.10 Towards these aims, unadjusted MUAC has many advantages over WHZ: it is 
cheap, simple, quick and acceptable;11 colour-coded  tapes mean that even illiterate carers or 
fieldworkers can easily interpret measurements. A recent study found mothers can correctly use 
colour-coded MUAC tapes, increasing early detection.12 In contrast WHZ assessment requires: 
scales; a length/height board that can be troublesome to transport and use in field settings, 
especially with young infants; sufficient numeracy and literacy to use a look-up table to convert raw 
measurements into a WHZ category. 
MUAC was eventually endorsed by the World Health Organization (WHO) and other UN agencies 
as an independent diagnostic criterion for SAM.13, 14The latest guidelines define SAM in 6-59 
month-olds as: WHZ <-3.0 (with reference to the 2006 WHO growth standards) and/or MUAC 
<115mm and/or bilateral pitting oedema.15  However, despite the practical advantages of MUAC 
and its widespread use in CMAM programmes, there have been many debates about whether it 
should – or could - replace WHZ entirely.16-19 
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Whilst the validity of MUAC-only based enrolment into nutritional care is well established,8, 9, 19-21 
evidence for its use monitoring patient progress and deciding on readiness for discharge is limited 
to one recent study of outpatient treatment of SAM in Malawi. They presented evidence that 
MUAC≥125mm at a discharge criterion was associated with low levels of relapse and mortality 
during a 3-month follow up.22 Thie limited evidence bases is a critical barrier to MUAC-only 
programming. Despite Llatest guidance suggestsing using MUAC ≥125mm for discharge, on the 
basis that mortality risk is very low above this threshold, more data is needed to know the 
implications of this recommendation.11, 15. However, more data is needed to know the implications 
of this recommendation.  
Our study sought to assess the adequacy of using MUAC for monitoring nutritional recovery, by 
confirming that changes in MUAC reflect response to treatment, and to assess the use of MUAC 
criteria for discharge of children with SAM. fill this evidence gap by looking at data from a rural 
Nutrition Rehabilitation Unit (NRU) in The Gambia over 10 years of admissions. We use data over 
10 years of admissions, from a rural Nutrition Rehabilitation Unit (NRU) in The Gambia, a West 
African country with low HIV exposure. By evaluating the changes in MUAC, WHZ and weight 
during nutritional rehabilitation and at discharge, we aimed to evaluate MUAC and WHZ 
performance as tools for SAM treatment programme monitoring and discharge.  
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Materials and Methods 
Setting 
The Gambia is situated in West Africa and is home to less than 2 million people. Malnutrition is a 
significant public health problem in children under 5-years, with recent statistics reflecting serious 
levels of wasting (≥10%).23 
The Medical Research Council, Keneba Nutrition Rehabilitation Unit (NRU) is located in the West 
Kiang region with a population of 15,117.24 It is integrated into a clinic that has been providing free 
primary health care services for over four decades. The NRU currently admits some 70-100 
children per year and provides outpatient care following limited inpatient care (maximum of 48 
hours) using Therapeutic milk (F75, F100), Ready-to-Use-Therapeutic Food (Plumpynut®; 
Malaunay, France)25 and/or enriched Pap (maize meal porridge with milk, oil and ground nut 
paste). Historically, discharge was from the MRC Keneba NRU outpatient phase was by WHZ ≥-
2.00 (NCHS growth references until 2006) but with the roll-out of CMAM in 2013, children with a 
WHZ ≤-3.0 (WHO growth standards) and no medical complications are now transferred to 
community-based care for continued care.  
Study design and study population and data sourcing 
This was an observational, retrospective secondary data analysis of routinely collected 
anthropometric data from children aged 6-59 months-of-age who were admitted for the first time to 
the MRC Keneba NRU with a diagnosis of: “marasmus”; "severe acute malnutrition" or "protein 
energy malnutrition" between January 2003 and December 2013. We included those with severe 
wasting (marasmus) defined as WHZ <-3.0 (WHO growth standards) and/or MUAC <115mm. From 
2008-2009 the NRU used a MUAC cut-off of 110mm, prior to this MUAC was not used for 
admission but only WHZ <-3.0 and/or oedema. We excluded children with kwashiorkor from our 
analysis due to the different weight gain trends over treatment and the small numbers in the 
population. We also excluded any readmissions since these were more likely to be atypical cases 
with complex problems underlying SAM. 
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Height, weight and MUAC were recorded at admission, weekly and at discharge by NRU staff. 
Height was recorded to the nearest millimetre using a Seca length board; weight was recorded to 
the nearest 10 grams using electronic Seca sitting scales; MUAC was measured using various 
MUAC tapes, differing over time and including both colour coded and plain tapes. All however 
measured to the nearest millimetre. 
Data for this secondary analysis was extracted from the MRC Keneba NRU database. This 
comprised patient data entered in Access (Microsoft) soon after a child was discharged, using a 
double-entry method for validation. Oedema status had not been captured initially so was sourced 
from hard copy patient files in July 2014.  
Z-scores were calculated using Emergency Nutrition Assessment (ENA) for SMART Software 
(Version October 2007)26 with reference to the 2006 WHO MGRS growth curves using weight and 
height as recorded in the database, and age calculated by ‘date of admission – date of birth’.27  
Recovery Exposure variables wasere defined as MUAC ≥125 mm at discharge, as recorded in the 
database, and/or WHZ ≥-2.00 at discharge as calculated from weight and height recorded in the 
database, with reference to WHO MGRS growth curves. The following recovery variables were 
defined as follows: recovered by MUAC (%): (number discharged at MUAC ≥125 mm/ total number 
of children))*100; not recovered by MUAC (%): (number discharged at MUAC<125mm/ total 
number of children)*100; recovered by WHZ (%): (number discharged at WHZ ≥-2.00 mm/ total 
number of children)*100; and, not recovered by WHZ (%): (number discharged at WHZ <-2.00/ 
total number of children)*100. 
Recovery indicators were calculated as: Weight gain = [(discharge weight (g) - minimum weight 
(g))/ minimum weight (kg)]/ length of stay (days); MUAC gain = (discharge MUAC (mm) – minimum 
MUAC (mm))/length of stay (days); Length of stay = number of days treated at the NRU (day of 
admission = 1). 
Treatment outcomes were assessed by readmissions (%): (number of first readmissions to the 
NRU within study timeframe/ number of first admissions within the study timeframe) * 100; default: 
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carer leaving against medical advice or absconding; death: death whilst in treatment at the NRU 
(follow up information on short-term mortality not available); and referral: referral to hospital or 
health centre when patients had medical complications which were beyond the capability of the 
NRU to treat. 
Statistical Methods 
We used STATA software (version 13.1) for all statistical analysis.28 Distributions were first visually 
assessed for normality. Outliers were identified and the standard cleaning criteria applied to 
admission anthropometric measurements, on the basis that they more likely represent data errors 
than true values,29 cases with the following were dropped: -6.00> WHZ >-1.00; HAZ <-6.00; WAZ 
<-6.00; 80mm< MUAC <140mm; weight gain >30g/kg/day. 
Appropriate average measures were calculated for analysis. Means (SD) were reported for 
variables with approximate normal distribution (weight, height, WHZ, HAZ, MUAC, weight gain) 
and medians [IQR] or geometrical means [IQR] for those with skewed distributions (age, length of 
stay). Data trends were explored graphically for descriptive analysis. 
For comparison of treatment outcomes and indicators of WHZ to MUAC discharge thresholds, 
Cchi2 tests were used for comparisons across categorical outcomes, and . T-tests were used for 
comparisons of quantitative variables across a binary outcomes. For comparison of treatment 
outcomes and indicators across all discharge categories (met WHZ criteria only, met MUAC criteria 
only, met both criteria, met none of the criteria), and ANOVA and Scheffe’s test were used when 
the outcome was categorical and . Nnon-parametric trend tests were used to test for linear trends 
of a non-normal quantitative variable across categories. 
Pearson’s correlation coefficient was used to test for correlations between weight, WHZ and MUAC 
as well as between MUAC gain and weight gainquantitative variables. Logistic regression was 
used to test the linear relationship of treatment indicators (weight gain and length of stay) s for 
significance with binary discharge categories of MUAC ≥125mm and WHZ ≥-2.0. Potential 
confounders and modifiers such as age at admissions, sex and presence of stunting (HAZ<-2.0) 
were tested in models and respective admission measurements were controlled for. Treatment 
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length was log transformed for comparisons between groups by t-test and for use in logistical 
regression as a quantitative variable. ROC-curves were generated using Stata Software to test 
how weight gain over treatment predicted discharge above dichotomised discharge threshold 
variables, set as: MUAC≥125mm and WHZ≥-2.0. 
Cases with random missing measurements were excluded. Cases with non-random missing data 
were made in to a sub-group and compared to cases with complete data for admission 
measurements before exclusion. 
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Results 
Participants 
The flow chart in Figure 1 outlines how eligible children were selected, summarizing exclusions on 
case criteria, extreme values and missing measurements. 
Four hundred and sixty three children with marasmus were included in the final analysis. The 
majority of cases (455/465; 97.8%) were under 36 months-old. High levels of severe underweight 
(394/465; 84.75%) and stunting (267/465; 57.48%) underlying the marasmus were evident (Table 
1). There was a 59.860% (279/465) overlap between WHZ and MUAC in SAM admission criteria in 
this population, 32.83% (152/465) met only WHZ admission criteria, and 6.97% (32/465) met only 
MUAC admission criteria (Figure S1, online supplementary material). 
Outcome data 
On average, absolute weight gain was 1.04 kg (SD=0.060), absolute MUAC gain was 11 mm 
(IQR=SD=76; 16) and absolute WHZ gain was 1.68 (SD=0.88). The mean rate of weight gain was 
8.9 g/kg/day (SD=4.7) and mean rate of MUAC gain was 0.6 mm/day (IQR=0.3; 0.8)SD=0.4). The 
median time in treatment was 18 days [IQR=13, 25].  
By MUAC, 36.1% (167/463) of children admitted were classified as recovered, whilst 63.9% 
(296/463) did not recover. By WHZ, 45.6% (211/463) recovered, whilst 54.5% (252/463) did not. 
Other Ttreatment outcomes included: 4.1% (n=19) defaultedrs, 3.2% (n=15) were referred referrals 
to hospital and 1.1% (n=5) died whilst in treatmentpatient deaths. Over the 10 years, 6.0% (n=32) 
of patients were readmitted. 
Monitoring nutritional recovery 
The average weight, WHZ and MUAC ran in parallel, both increasing during treatment. There was 
significant positive correlation between percentage MUAC gain (mm) and percentage weight gain 
(g) (Rr2=0.50, r=0.71; p<0.001) (Figure 2).  
The mean percentage MUAC gain was 10.2% (SD=7.4). Weight gain showed similar patterns with 
an average of 16.8% (SD=9.7).There were a large number of cases with 0% MUAC gain; when 
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explored the majority of these were cases referred to hospital (Figure S2, online supplementary 
material).  
Discharge criteria  
Table 2 summarises treatment indicators and outcomes in relation to WHZ and MUAC discharge 
criteria (see Table S1, online supplementary material, for full results by thresholds). Those ending 
their stay with WHZ ≥-2.0 had a statistically greater mean rate of weight gain than those ending 
treatment with MUAC ≥125mm (diff=-1.44 [-2.34, -0.54; p=0.001) and a higher average WHZ gain 
(diff:-0.014 [-0.03, -0.002]; p=0.02). Those ending their stay with MUAC ≥125mm had a statistically 
higher MUAC on discharge than those with WHZ ≥-2.0 (diff: 60.0 [46.0, 74.0]; p<0.001). There 
were no significant differences in: mean MUAC gain (p=0.47), length of stay (p=0.85) and number 
of readmissions (p=0.17). The number referred to hospital was zero for both and defaulters were 
too small a number to draw any valid conclusions.  
Table 3 shows that overall those with MUAC≥125mm at end of stay had good outcomes and 
treatment indicators. However, cases who only met MUAC discharge criteria (i.e. WHZ <-2.0) by 
end of stay had lowest weight gain on average at 7.0 g/kg/daymm (SD=4.0), significantly lower 
than those who met only WHZ discharge criteria (Scheffe’s test; p<0.001) and those who met both 
discharge criteria (Scheffe’s test; p<0.001). It did not differ significantly from those who did not 
meet either discharge criteria (Scheffe’s test; p=0.72). Table 3 also shows in comparison to those 
meeting both discharge criteria, those meeting MUAC discharge only had a significantly lower 
MUAC gain (p=0.0016), but no difference in length of stay (p=0.88) or readmissions (p=0.11). 
Number of defaulters was too small to draw any valid conclusions. 
Those who ended their stay with MUAC <125mm were significantly younger (diff: 4.07 [2.73, 5.41]; 
p<0.001), more likely to be female (p=0.0060) and more likely to be stunted (p=0.001) at admission 
than those ending their stay with MUAC ≥125mm. 
9 
 
Logistic regression models 
Logistic regression applied to the outcome of MUAC ≥125mm, adjusting for respective admission 
measurement and age, confirmed that length of stay (days) was not significantly associated with a 
case being at MUAC ≥125mm (OR: 1.25 [0.88, 1.77]; p=0.22) or at WHZ≥-2.0 (OR: 1.19 [0.85, 
1.67]; p=0.31) at end of stay (see Supplementary Regression Models, online supplementary 
material, for regression models). 
Logistic regression showed that ending stay with MUAC ≥125mm (OR: 1.06 [1.00, 1.11]; p=0.032) 
and WHZ ≥-2.0 (OR: 1.27 [1.20, 1.35]; p<0.001) predicted higher weight gain (g/kg/day). The 
MUAC ≥125mm model explained 26% of the variation, more than that of the equivalent WHZ ≥-2.0 
model at 20%; both models were controlled for respective admission measurement and age (see 
Supplementary Regression Models, online supplementary material, for regression models). Figure 
S3 (online supplementary material) shows this graphically, with a greater Area Under the Curve 
(AUC) in the MUAC ROC curve. 
Other analyses 
Sensitivity analyses were run for cases with non-random missing data (Supplementary Sensitivity 
Analyses, online supplementary material). Neither including cases with missing discharge MUAC 
(n=8) or WHZ (n=7) only, or excluding those missing oedema status (n=12) made a significant 
difference to the overall results. Controlling for area of inhabitance also made no significant 
difference to the overall results. Defaulters (n=19) had a significantly lower admission MUAC (diff: 
0.46 [95% CI: 0.038, 0.891] p=0.033) than non-defaulters. There was no significant difference in 
any other admission measurements. 
  
10 
 
Discussion 
Monitoring nutritional recovery 
Our results support the hypothesis that serial MUAC measurements are suitable for monitoring 
nutritional recovery: over the days of treatment observed, there was a clearly observable increase 
in both absolute MUAC and percentage% MUAC change from baseline. Another key finding was 
that MUAC changes ran in parallel to WHZ and weight, with percentage MUAC gain change 
showing a positive correlation with percentage weight gainchange. A recent paper demonstrated 
this correlation between MUAC change and weight change in data from three separate countries: 
Ethiopia, Malawi and Bangladesh. They also found that MUAC and weight showed similar changes 
during periods of illness during SAM treatment, both reducing rapidly.30 
These findings are consistent with  reports from a large scale analysis of 24,792 patients of a 
Therapeutic Feeding Programme in Burkina Faso which used MUAC for admission.31  One of their 
programmes in India also reported MUAC to function as an acceptable monitoring tool after 
assessing discharge WHZ, length of stay and average weight gain of cases admitted and 
discharged on MUAC.32 MSF have since adopted MUAC-only programming for SAM treatment 
programmes, with successful programme outcomes.19 
Discharge criteria 
Our results showed that discharge above both MUAC and WHZ thresholds of ≥125mm and ≥-2.0, 
respectively, predicted a higher rate of weight gain. both MUAC and WHZ discharge 
thresholdspredicted higher weight gain. However, MUAC had a greater predictive ability for weight 
gain when controlled for admission age and admission measurement. Length of stay was not found 
to differ by MUAC or WHZ status at discharge. MSF reported similar findings from a CMAM 
programme in North Sudan using MUAC ≥125mm for discharge. When 753 cured cases were 
reclassified by their WHZ status similar trends were seen in weight gain and length of stay.33 When 
interpreting weight gain with relation to MUAC we must keep in mind that weight gain is not a ‘gold-
standard’ for recovery rate.  
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Our results showed that, despite lower weight gain, those ending their stay with MUAC ≥125mm 
had on average a 6mm higher MUAC than those ending their stay with WHZ≥-2.0. Absolute MUAC 
has been shown to be closely related with mortality, more so than low weight gain, which implies 
that those discharged at the MUAC threshold may be less at risk than those discharged at the 
WHZ threshold.11 
Perhaps more importantly readmissions, defaulters and length of stay did not differ significantly by 
MUAC or WHZ status at discharge. There is indication that readmissions do not differ, however as 
there was no standard follow-up process after discharge, data may not be fully representative. 
Both a low MUAC and low WHZ predicted default and referral to hospital as well as all inpatient 
deaths being below both thresholds. In fact in those referred we see very little MUAC gain; as 
these cases would have been referred early on during the intensive phase MUAC and weight gain 
would not have begun. 
MUAC-only programming 
MUAC predicts outcomes and treatment progress similar to WHZ in this population. One potential 
implication of this observation is that programme outcomes would be similar if MUAC alone was 
used for discharge. This would enhance existing arguments for MUAC-programming: simplicity and 
coverage; and better reliability and validity than WHZ measurements.11, 21, 34 A concern with 
replacing WHZ entirely is the difference in populations identified as SAM: this is different in 
different populations.35 Studies in South-East Asia show MUAC to identify a much smaller 
population of SAM children than WHZ.36, 37 Whereas in Kenya a 70% overlap has been reported. 8 
It has been suggested that these geographical differences are due to differences in body shape.20 
MUAC also identifies a younger, more female and more stunted population 'at-risk' which some 
argue is a desirable characteristic, 8, 18 whilst others argue that the use of WHZ should continue as 
it effectively controls for these factors.17 
In our population only 24% fulfil both discharge criteria simultaneously. Those meeting MUAC 
discharge only criteria in our population i.e. MUAC ≥125mm with WHZ<-2.0 had significantly lower 
weight gain and MUAC gain than those meeting both MUAC and WHZ criteria. Importantly from a 
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safety viewpoint, there was indication in our data that thisis was not associated with an increase in 
readmissions. This finding is supported by a recent study which included follow-up data on 258 
children treated for SAM in Malawi. Children were discharged by MUAC ≥125mm and followed up 
for 3-months. They observed low levels of relapse to SAM and low mortality, concluding that 
MUAC was a safe discharge criterion.22 
There must be caution in using MUAC-only programming without sufficient evidence for the longer 
term outcomes of this subgroup, and careful follow-up would be recommended. However, Aan 
MSF Therapeutic Feeding Programme (TFP) in Bihar reported a significantly higher relapse rate in 
a minority of cases (2%) who were discharged by MUAC but with WHZ<-3.0.38 The question which 
must be answered is whether this minority are ‘at-risk’ of mortality. A study in Bangladesh showed 
that children at WHZ<-3.0 did not deteriorate over 3-months when left without nutritional 
intervention and in fact some improved, but this evidence base needs strengthening and careful 
follow-up of cases discharged by MUAC-only would be recommended.39There must be caution in 
using MUAC-only programming without sufficient evidence for the longer term outcomes of this 
subgroup, and careful follow-up would be recommended. 
Limitations 
The limitations of this study include that the Keneba Electronic Medical Records System 
(KEMReS) did not alert for low MUAC during the time of the study, but only for low WHZ. MUAC 
screening was also not commonplace in this area and hence most admissions were based on 
WHZ. Only 7% were admitted on MUAC only meaning the study sample is not fully representative 
of the SAM population and results may not reflect the true results limiting extrapolation. In addition 
stunting is at a serious level in this population, meaning results may not apply so well to less 
stunted populations. We were also unable to access adequate admission morbidity data to include 
in this analysis. 
Our data is from a treatment programme which delivers care through initial (maximum 48 hours) 
inpatient treatment, therefore findings may not be generalizable to the outpatient treatment 
approach (CMAM) currently used in the majority of contexts.  
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Community programmes varied in extent and were limited, this means that many relapses may 
have been identified through passive referral. In addition, the follow-up procedures in place relied 
on patients representing to the clinic for review at one week and four weeks after discharge with no 
community follow-up. This likely underestimates the number of patients who were readmitted and 
means outcomes of the majority of children after treatment are . unknown. However, this is useful 
baseline information for this population, demonstrating previous findings in a novel context. Future 
work should incorporate the follow-up of these patients. 
Another limitation is that we used operational data. Anthropometry for instance was only measured 
once rather than double measured as for research studies. However, large numbers mean that the 
larger resulting ‘noise’ in the data does not affect our final conclusions so much. Missing data is 
also an issue. Missing discharge data was mainly due to default and these cases were excluded, 
as defaulters had significantly lower admission MUAC and weight gain. In a sensitivity analysis 
including missing data cases made no significant difference to our overall results. Missing data and 
defaulters are a reality in any nutritional programme and especially since numbers were low in 
ours, we do not believe any they made any major differences to our conclusions.  
The fact that SAM case definitions have changed over the 10-year study period also may affect the 
generalisability of our results to current SAM treatment programmes. Reference data for WHZ 
changed from NCHS to MGRS WHO growth curves in 2006, meaning calculated WHZ values for 
analysis will not be those used at the time for cases before 2006. However, running analyses using 
WHZ with reference to NCHS data made little difference to results. On the positive side, at least 
protocols for treatment have been stable over the period of our investigation. 
Conclusions  
We conclude that monitoring MUAC changes has potential for monitoring treatment progress and 
nutritional recovery of children in treatment for SAM: MUAC tracks well alongside weight and WHZ 
changes. MUAC ≥125mm shows potential as a discharge criterion, predicting treatment outcomes 
with a similar ability to WHZ and leading to the same average length of stay. Rate of weight gain 
and MUAC gain areis lower in those meeting MUAC≥125mm only at discharge but there do not 
14 
 
appear to be adverse consequences of this in terms of there being no significant difference in 
numbers of readmissions. Additionally, those meeting the MUAC threshold at end of stay showed a 
higher absolute measure that has been shown to be related to a lower risk of mortality, than those 
meeting the WHZ threshold. Future research could focus on longer term outcomes of these cases 
and further refine the criteria for monitoring the rate of recovery and discharge. In the meantime, if 
MUAC-only programming is used, careful follow-up is advised particularly for those children whose 
MUAC gain is slow. We encourage routine reporting of MUAC gain over treatment to enable 
comparisons between nutritional programmes and setting of ideal rates, as is currently in place for 
weight gain. 
  
15 
 
Authors statements 
Authors’ contributions 
AB led the work, analysed the data and wrote the first draft of the paper; MK developed the original 
concept for the research and supervised the project; HN supervised the project and will be the 
guarantor for the manuscript; all authors read and contributed to the development of the 
manuscript and approved the final version. 
Acknowledgments 
We would like to thank Dr Rita Wegmuller, Head of Station, and the MRC Gambia Unit for hosting 
the field research. We would also like to thank the MRC Keneba Nutrition Rehabilitation Unit staff 
for supporting the field research. We would like to thank Mr Musa Jarjou and Mr Yaya Minteh of 
MRC Keneba for their help in collating the data. We would like to thank Prof Andrew Prentice and 
Dr Sophie Moore for supporting the use of the MRC data for the research question. We would like 
to thank Dr Phil Edwards for his advice on a number of statistical queries.  
Funding 
Funding was received from the UK Medical Research Council 24 and the UK Department for 
International Development (DFID), under the MRC/DFID Concordat agreement [Grant MC-A760-
5QX00]. The LSHTM Trust Fund awarded a bursary to cover the costs of flight to The Gambia. All 
Saints Educational Trust (ASET) awarded a bursary for tuition fees and maintenance to the 
corresponding author to be able to study the Nutrition for Global Health MSc programme for which 
this research was part of. 
Competing interests 
None declare 
Ethical Approval 
Ethical approval was successfully sought prior to commencement of the study from both The 
Gambia Government/MRC Joint Ethics Committee (ref: SCC 1375) and the LSHTM MSC 
Research Ethics Committee (ref: 7852).  
16 
 
References 
1. Black RE, Victora CG, Walker SP, et al.; Maternal and child undernutrition and overweight in 
low-income and middle-income countries. Lancet 2013;382(9890):427-51. doi: 10.1016/s0140-
6736(13)60937-x. 
2. Liu L, Johnson HL, Cousens S, et al.; Global, regional, and national causes of child mortality: 
an updated systematic analysis for 2010 with time trends since 2000. The Lancet 
2012;379(9832):2151-2161. 
3. UNICEF, WHO, Bank. TW; UNICEF – WHO – The World Bank: Joint child malnutrition 
estimates - Levels and trends. 2013. 
4. WHO. Management of severe malnutrition: a manual for physicians and other senior health 
workers. World Health Organisation. 
http://www.who.int/nutrition/publications/en/manage_severe_malnutrition_eng.pdf (Date Accessed 
1999 Accessed, date last accessed) 
5. Collins S; Treating severe acute malnutrition seriously. Arch Dis Child 2007;92(5):453-61. 
doi: 10.1136/adc.2006.098327. 
6. Vella V, Tomkins A, Ndiku J, et al.; Anthropometry as a predictor for mortality among 
Ugandan children, allowing for socio-economic variables. Eur J Clin Nutr 1994;48(3):189-97. 
7. Briend A, Maire B, Fontaine O, et al.; Mid-upper arm circumference and weight-for-height to 
identify high-risk malnourished under-five children. Maternal & Child Nutrition 2012;8(1):130-133. 
doi: 10.1111/j.1740-8709.2011.00340.x. 
8. Berkley J, Mwangi I, Griffiths K, et al.; Assessment of severe malnutrition among hospitalized 
children in rural kenya: Comparison of weight for height and mid upper arm circumference. JAMA 
2005;294(5):591-597. doi: 10.1001/jama.294.5.591. 
9. Mwangome MK, Fegan G, Fulford T, et al.; Mid-upper arm circumference at age of routine 
infant vaccination to identify infants at elevated risk of death: a retrospective cohort study in the 
Gambia. Bull World Health Organ 2012;90(12):887-94. doi: 10.2471/blt.12.109009. 
10. Collins S, Sadler K, Dent N, et al.; Key issues in the success of community-based 
management of severe malnutrition. Food Nutr Bull 2006;27(3 Suppl):S49-82. 
11. Myatt M, Khara T, Collins S; A review of methods to detect cases of severely malnourished 
children in the community for their admission into community-based therapeutic care programs. Food 
Nutr Bull 2006;27(3 Suppl):S7-23. 
17 
 
12. Blackwell N, Myatt M, Allafort-Duverger T, et al.; Mothers Understand And Can do it (MUAC): 
a comparison of mothers and community health workers determining mid-upper arm circumference 
in 103 children aged from 6 months to 5 years. Archives of Public Health 2015;73(1):26. doi: 
10.1186/s13690-015-0074-z. 
13. WHO, WFP, UNSCN, et al.; Community-based management of severe acute malnutrition: a 
joint statement. 2007. 
14. WHO, UNICEF; WHO child growth standards and the identification of severe acute 
malnutrition in infants and children: A Joint Statement by the World Health Organization and the 
United Nations Children's Fund. 2009. 
15. WHO; Guideline: Updates on the management of severe acute malnutrition in infants and 
children. Geneva: World Health Organisation, 2013. 
16. ENN. Mid Upper Arm Circumference and Weight-for-Height Z-score as Indicators of Severe 
Acute Malnutrition: A consultation for operational agencies and academic specialists to better 
understand the evidence, identify knowledge gaps and to inform operational guidance  
http://www.ennonline.net/ourwork/othermeetings/muacwhzscores (Date Accessed 2012 Accessed, 
date last accessed) 
17. Roberfroid D, Hammami N, Lachat C, et al.; Utilization of mid-upper arm circumference 
versus weight-for-height in nutritional rehabilitation programmes: a systematic review of evidence. 
Geneva, Switzerland: World Health Organisation (WHO), 2013. 
18. Dasgupta R, Sinha D, Jain S, et al.; Screening for SAM in the community: Is MUAC a ‘Simple 
Tool’? Indian Pediatrics 2013;50(1):154-155. doi: 10.1007/s13312-013-0032-1. 
19. Phelan K, Lanusse C, van der Kam S, et al.; Simplifying the response to childhood 
malnutrition: MSF’s experience with MUAC-based (and oedema) programming. Field Exchange 
2015(50):108. 
20. Myatt M, Duffield A, Seal A, et al.; The effect of body shape on weight-for-height and mid-
upper arm circumference based case definitions of acute malnutrition in Ethiopian children. Ann Hum 
Biol 2009;36(1):5-20. doi: 10.1080/03014460802471205. 
21. Mwangome MK, Berkley JA; The reliability of weight-for-length/height Z scores in children. 
Maternal & Child Nutrition 2014:n/a-n/a. doi: 10.1111/mcn.12124. 
22. Binns PJ, Dale NM, Banda T, et al.; Safety and practicability of using mid-upper arm 
circumference as a discharge criterion in community based management of severe acute 
18 
 
malnutrition in children aged 6 to 59 months programmes. Archives of Public Health 2016;74(1):24. 
doi: 10.1186/s13690-016-0136-x. 
23. The Gambia Bureau of Statistics. The Gambia Population and Housing Census 2013 
Provisional Report. http://www.gbos.gov.gm/2013.php (Date Accessed 2013 Accessed, date last 
accessed) 
24. Demographic Surveillance System MK; Population Statistic. 2014. 
25. Nutriset. Nutriset. http://www.nutriset.fr/en/homepage-nutriset.html (Date Accessed 1996 
Accessed, date last accessed) 
26. Nutrisurvey. ENA for SMART. http://www.nutrisurvey.de/ena/ena.html (Date Accessed 2007 
Accessed, date last accessed) 
27. WHO, Group MGRS; WHO Child Growth Standards: Length/ height-for-age, weight-for-age, 
weight-for-length, weight-for-height and body mass index-for-age: Methods and development. 
Geneva: World Health Organisation, 2006. 
28. StataCorp. Stata Statistical Software: Release 13. www.stata.com (Date Accessed 2013 
Accessed, date last accessed) 
29. Crowe S, Seal A, Grijalva-Eternod C, et al.; Effect of nutrition survey 'cleaning criteria' on 
estimates of malnutrition prevalence and disease burden: secondary data analysis. PeerJ 
2014;2:e380. doi: 10.7717/peerj.380. 
30. Binns P, Dale N, Hoq M, et al.; Relationship between mid upper arm circumference and 
weight changes in children aged 6-59 months. Arch Public Health 2015;73:54. doi: 10.1186/s13690-
015-0103-y. 
31. Goossens S, Bekele Y, Yun O, et al.; Mid-Upper Arm Circumference Based Nutrition 
Programming: Evidence for a New Approach in Regions with High Burden of Acute Malnutrition. 
PLoS ONE 2012;7(11):e49320. doi: 10.1371/journal.pone.0049320. 
32. Burza S, Mahajan R, Marino E, et al.; Community-based management of severe acute 
malnutrition in India: new evidence from Bihar. The American Journal of Clinical Nutrition 
2015;101(4):847-859. doi: 10.3945/ajcn.114.093294. 
33. Dale NM, Myatt M, Prudhon C, et al.; Using Mid-Upper Arm Circumference to End Treatment 
of Severe Acute Malnutrition Leads to Higher Weight Gains in the Most Malnourished Children. PLoS 
ONE 2013;8(2):e55404. doi: 10.1371/journal.pone.0055404. 
19 
 
34. Mwangome MK, Fegan G, Mbunya R, et al.; Reliability and accuracy of anthropometry 
performed by community health workers among infants under 6 months in rural Kenya. Trop Med Int 
Health 2012;17(5):622-9. doi: 10.1111/j.1365-3156.2012.02959.x. 
35. Grellety E, Golden MH; Weight-for-height and mid-upper-arm circumference should be used 
independently to diagnose acute malnutrition: policy implications. BMC Nutrition 2016;2(1):1-17. doi: 
10.1186/s40795-016-0049-7. 
36. Cichon B; MUAC versus weight-for-height debate in the Philippines. Field Exchange: 
Emergency Nutrition Network ENN, 2012, 3-5. 
37. Laillou A, Prak S, de Groot R, et al.; Optimal Screening of Children with Acute Malnutrition 
Requires a Change in Current WHO Guidelines as MUAC and WHZ Identify Different Patient 
Groups. PLoS ONE 2014;9(7):e101159. doi: 10.1371/journal.pone.0101159. 
38. Burza S, Mahajan R, Salse N, et al.; Mid Upper Arm Circumference (MUAC) ≥120mm as a 
simple, safe and effective discharge criterion in community management of Severe Acute 
Malnutrition (SAM) in Bihar, India. ISSUU: Medecins Sans Frontieres Publication 2013. 
39. Ali E, Zachariah R, Shams Z, et al.; Is mid-upper arm circumference alone sufficient for 
deciding admission to a nutritional programme for childhood severe acute malnutrition in 
Bangladesh? Trans R Soc Trop Med Hyg 2013;107(5):319-323. doi: 10.1093/trstmh/trt018. 
  
20 
 
Legends to Figures 
Figure 1  
Flow chart showing participant selection with exclusions on case criteria, extreme values 
and missing data 
Flow chart outlining the exclusions made from the original population of all admissions to the MRC 
Gambia NRU within the study timeframe (n=702). Criteria are not mutually exclusive. Overall 239 
cases were excluded, leaving 463 eligible cases in the study population. (Note: overlap in cases with 
extreme values and missing measurements therefore numbers not additive for exclusions) 
Figure 2  
The positive linear correlation between percentage weight gain and percentage MUAC gain, 
for all 463 marasmus cases included in the study population. 
Blue dots (percentage weight gain and percentage MUAC gain); red line (fitted line to demonstrate 
positive correlation) 
 
 
 
Supplementary Figure S1: Venn diagram of SAM admission criteria: WHZ < -3.0 and 
MUAC < 115mm for all 463 marasmus cases included.  
MUAC: mid-upper arm circumference, WHZ: weight-for-age z-score 
 
33%                            60%                          7%                                                                              
WHZ < -3.00 MUAC < 115mm 
Supplementary Figure 1 Click here to download Supplementary Figure Supplementary
Figure S1.pdf
Figure S3: ROC curves for logistical regression models on WHZ ≥-2.0 and MUAC 
≥125mm with: A. weight gain, B. weight gain adjusted for admission measurement 
and age and C. length of stay 
A. i. WHZ and ii. MUAC with weight gain
 
0
.0
0
0
.2
5
0
.5
0
0
.7
5
1
.0
0
S
e
n
s
it
iv
it
y
0.00 0.25 0.50 0.75 1.00
1 - Specificity
Area under ROC curve = 0.7266
0
.0
0
0
.2
5
0
.5
0
0
.7
5
1
.0
0
S
e
n
s
it
iv
it
y
0.00 0.25 0.50 0.75 1.00
1 - Specificity
Area under ROC curve = 0.5438
Supplementary Figure 3 Click here to download Supplementary Figure Supplementary
Figure S3.pdf
 B. i. WHZ and ii. MUAC with weight gain controlled for admission measurement and age 
 
 
 
0
.0
0
0
.2
5
0
.5
0
0
.7
5
1
.0
0
S
e
n
s
it
iv
it
y
0.00 0.25 0.50 0.75 1.00
1 - Specificity
Area under ROC curve = 0.6566
0
.0
0
0
.2
5
0
.5
0
0
.7
5
1
.0
0
S
e
n
s
it
iv
it
y
0.00 0.25 0.50 0.75 1.00
1 - Specificity
Area under ROC curve = 0.8137
C. i. WHZ and ii. MUAC with length of stay 
 
WHZ: weight-for-age z-score, MUAC: mid-upper arm circumference 
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6-59 month-old children admitted  
To NRU Jan 2003-Dec 2013: 
n=702 
Cases included in final analysis: 
463 
Exclusions 
Not acute malnutrition (n=10) 
Moderate acute malnutrition (n=73) 
Oedematous malnutrition (n=50) 
Readmission cases (n=42) 
 
Extreme admission measurements: 
WHZ:>-1.0 (n=3), <-6.0 (n=10) 
HAZ<-6.0 (n=12) 
WAZ<-6.0 (n=21) 
MUAC: <80mm (n=2), >140mm (n=1) 
Weight gain >30g/kg/day (n=2) 
 
Missing data: 
Admission: WHZ (n=1), MUAC (n=1) 
Discharge: WHZ (n=38), MUAC 
(n=37) 
Weight gain (n=27) 
Figure 1
 Table 1. Demographics of the 463 marasmic cases included in the study 
Baseline data 
n/ mean %/ SD 
Median age (months) [IQR] 14 [11;20] 
   6-11 months 159 34 
  12-23 months 243 53 
   24-35 months 53 11 
  36-47 months 7 2 
  48-59 months 3 1 
Male 256 55 
Mean weight (kg) (SD) 6.36 1.13 
Severely Underweight (WAZ<-3.0) 394 85 
Mean Height (cm) (SD) 72.0 6.5 
Stunted (HAZ<-2.0) 267 58 
Mean WHZ (SD) -3.78 0.66 
Mean MUAC (mm) (SD) 111 93 
HAZ: height-for-age z-score, MUAC: mid-upper arm circumference, SD: standard deviation; WAZ: 
weight-for-age z-score, WHZ: weight-for-age z-score 
Table 1
Table 2. Average treatment and discharge outcomes for children who reached either MUAC 
and/or WHZ discharge criteria. Results of statistical significance tests are shown, comparing 
outcomes between discharge by MUAC and discharge by WHZ  
Mean treatment indicators 
and outcomes (SD) 
MUAC ≥125 
(n=167) 
WHZ ≥-2.0  
(n=211) 
Difference 
[95% CI] 
p-value 
Weight gain (g/kg/day)  9.6 (5.0) 11.0 (4.5) -1.4 [-2.34,-0.54] 0.001 
MUAC gain (mm/day)  0.74 (0.45) 0.71 (0.42) 0.03 [-0.06, 0.12] NSa 
WHZ gain (z-score/ day) 0.11 (0.06) 0.12 (0.06) 0.01 [0.03, -0.002] 0.023 
Length of stay (days)      
   Median [IQR] 19 [13,26] 18 [13,26] NAc NSa 
   Meanb [95% CI] 18.6 [17.2, 20.1] 18.3 [17.1, 19.6] NAc NAc 
Discharge MUAC (mm)  131 (48) 125 (80) 60 [46,74] <0.001 
Discharge WHZ  -1.82 (0.72) -1.53 (0.38) -0.29 [-0.40, -0.18] <0.001 
No. defaulted (%) 
3 (1.8%) 2 (0.9%) 
NAc NAc 
No. referred to hospital (%) 0 (0%) 0 (0%) NAc NAc 
No. readmission (%) 12 (7.1%) 8 (3.8%) NAc NSa 
MUAC: mid-upper arm circumference, WHZ: weight-for-height z-score  
aindicates non-significant result, p≥0.05; bgeometric mean; csample size too small for significance test. 
Table 2
Table 3 A comparison of outcomes by WHZ status for cases meeting MUAC discharge only 
(MUAC≥125mm). 
 
Treatment 
indicators and 
outcome 
Overall 
(n=168) 
WHZ ≥-2 
(n=113) 
WHZ <-2 
(n=54) 
Diff. 95% CI p-value 
Mean weight gain 
(g/kg/day) (SD) 
9.6 (5.0) 10.8 (5.0) 7.0 (4.0) 3.58 2.01, 5.14 <0.001 
Meana length of 
stay (days) [95% 
CI] 
19  
[13,26] 
18.4 
[16.7,20.4] 
18.7 
[16.3,21.3] 
NAb NAb NSc 
Mean MUAC gain 
(mm/day) (SD) 
0.7 (0.4) 0.8 (0.4) 0.6 (04) -0.23 -0.38, -0.09 0.0016a 
No. of defaulters 
(%) 
3 (1.8%) 0 (0%) 3 (5.6%) NAd NAd NAd 
No. of 
readmissions (%) 
12 (6%) 5 (4%) 7 (13%) NAd NAd NSc 
MUAC: mid-upper arm circumference; WHZ: weight-for-height z-score 
ageometric mean; b significance test not possible with geometric means; c indicates non-significant 
result, p≥0.05; dsample size too small for significance test. 
 
Table 3
Table S1. Average treatment and discharge outcomes by MUAC and WHZ discharge 
thresholds 
Mean treatment indicators 
and outcomes (SD) 
MUAC≥125 
(n=167) 
WHZ≥-2.0  
(n=211) 
MUAC<125 
(n=296) 
WHZ<-2.0 
(n=252) 
Weight gain (g/kg/day)  
9.6 (5.0) 11.0 (4.5) 8.6 (4.6) 7.3 (4.3) 
MUAC gain (mm/day)  0.74 (0.45) 0.71 (0.42) 0.49 (0.36) 0.47 (0.38) 
WHZ gain (z-score/day) 0.11 (0.06) 0.12 (0.06) 0.09 (0.05) 0.07 (0.05) 
Length of stay (days)      
   Median [IQR] 19 [13,26] 18 [13,26] 18 [12,25] 18 [12,25] 
   Meana [95% CI] 18.6 [17.2, 20.1]a 18.3 [17.1, 19.6]a   
Discharge MUAC (mm)  
131 (48) 125 (80) 116 (70) 118 (90) 
Discharge WHZ  -1.82 (0.72) -1.53 (0.38) -2.44 (0.84) -2.79 (0.71) 
No. defaulted (%) 
3 (1.8%) 2 (0.9%) 16 (5.4%) 17 (6.7%) 
No. referred to hospital (%) 0 (0%) 0 (0%) 15 (5.1%) 15 (6.0%) 
No. readmission (%) 12 (7.1%) 8 (3.8%) 20 (6.7%) 24 (9.5%) 
a geometric mean 
Supplementary Table S1 Click here to download Supplementary Table Supplementary
Table S1.docx
Supplementary Information: Logistic regression models 
A. Logistic regression models of MUAC≥ 125mm at discharge by weight gain, admission 
age, admission MUAC and sex 
 
MUAC≥ 125mm 
Odds 
ratio 
95% CI p-value 
Pseudo 
R2 
Model 1 
Weight gain (g/kg/day) 1.04 1.00, 1.09 0.037 0.006 
Model 2 Weight gain (g/kg/day) 1.06a 1.00 1.11 0.032 0.059 
 Admission age (months) 1.08a 1.05, 1.11 <0.001  
Model 3 Weight gain (g/kg/day) 1.05a 1.00, 1.11 0.048 0.268 
 Admission MUAC (cm) 4.34a 3.02, 6.23 <0.001  
 Admission age (months) 1.08a 1.04, 1.12 <0.001  
 Stunting (Yes-No) 0.61a 0.37, 1.02 NSb  
 Sex (Female-Male) 0.71a 0.44, 1.13 NSb  
Model 4 Weight gain (g/kg/day) 1.06a 1.00, 1.11 0.032 0.260 
 Admission MUAC (cm) 4.93a 3.48, 6.98 <0.001  
 Admission age (months) 1.07a 1.03, 1.11 <0.001  
 
B. Logistic regression models of WHZ≥ -2.0 at discharge by weight gain, admission age, 
admission WHZ and sex 
 
WHZ≥ -2 
Odds 
ratio 
95% CI p-value 
Pseudo 
R2 
Model 1 
Weight gain (g/kg/day) 1.22 1.16, 1.29 0.001 0.119 
Model 2 Weight gain (g/kg/day) 1.27a 1.20 1.35 <0.001 0.202 
 Admission WHZ 3.17a 2.21, 4.55 <0.001  
 Admission age (months) 1.05a 1.01, 1.08 <0.004  
Model 3 Weight gain (g/kg/day) 1.27a 1.20, 1.35 <0.001 0.203 
 Admission WHZ 3.10a 2.14, 4.49 <0.001  
 Admission age (months) 1.05a 1.01, 1.08 <0.004  
 Sex (Female-Male) 1.13a 0.73, 1.75 NSb  
aodds ratio is adjusted for all other variable in the section of the table; b indicates non-significant result, 
p≥0.05. 
 
Supplementary Regression Models Click here to download Supplementary Table Supplementary
Regression Models.docx
Supplementary Information: Sensitivity analyses 
A. Significance tests: cases with complete data and those with non-random missing 
discharge data 
 Mean (SD)  
 
Complete data 
(n=473) 
Missing data 
(n=52) 
p-value 
Admission age (months)  15.9 (7.7) 14.9 (6.5) NSa 
Male (%) 55 60 NSa 
Weight (kg) 6.3 (1.2) 5.9 (1.3) 0.028 
Height (cm) 71.7 (6.8) 70.1 (7.3) NSa 
WHZ -3.8 (0.8) -4.1 (1.1) NSa 
MUAC (mm) 11.1 (1.1) 10.6 (1.1) 0.0030 
Defaulters (%) 20 (4.2%) 7 (14.6%) <0.001b  
Referred to hospital (%) 16 (3.4%) 20 (41.7%) 
Cure (%) 210 (44.4%) 13 (27.1%) 
No cure (%) 227 (48.0%) 8 (16.7%) 
B. Regression analysis: cases with missing WHZ and MUAC data cases 
MUAC≥ 125mm Odds ratio 95% CI p-value 
Pseudo 
R2 
Weight gain (g/kg/day) 1.04 1.00, 1.09 NSa 0.0060 
Weight gain (g/kg/day) 1.03c 0.99 1.07 NSa 0.060 
Admission age (months) 1.08c 1.05, 1.12 <0.001  
Weight gain (g/kg/day) 1.05c 1.00, 1.11 NSa 0.27 
Admission MUAC (cm) 4.32c 3.01, 6.19 <0.001  
Admission age (months) 1.08c 1.04, 1.12 <0.001  
Stunting (Yes-No) 0.60c 0.36, 0.99 0.047  
Sex (Female-Male) 0.69c 0.43, 1.11 NSa  
Weight gain (g/kg/day) 1.05c 1.00, 1.11 0.046 0.27 
Admission MUAC (cm) 4.55c 3.18, 6.50 <0.001  
Admission age (months) 1.08c 1.04, 1.12 <0.001  
Stunting (yes-no) 0.63 0.38, 1.04 NSa  
aindicates non-significant result, p≥0.05; bchi2 test for association; codds ratio is adjusted for all other 
variable in the section of the table 
Supplementary Sensitivity Analyses Click here to download Supplementary Table Supplementary
Sensitivity Analyses.docx
Figure S2: Histogram showing overall percentage MUAC gain over treatment for 463 
marasmus cases 
 
MUAC: mid-upper arm circumference 
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